Connecting the Oncology Community

Save the Date! ASCO Review- Saturday, June 20, 2020

Nebraska Oncology Society

Nebraska Oncology Society is a non-profit organization that has been in existence since 1992. Our mission is to facilitate and promote interaction among the oncology community to enhance patient care through oncology research, education, and health care legislation.

We invite you to become involved!

New Clinical Trials

VIEW ALL CLINICAL TRIALS

Study of Venetoclax (ABT199) Plus Chemoimmunotherapy for MYC/BCL2 Double-Hit and Double Expressing Lymphomas (A051701)

Phase II

LEARN MORE

Study of pembrolizumab with or without lenvatinib to evaluate the safety and efficacy of pembrolizumab and lenvatinib as 1L intervention in a PD-L1 population with recurrent or metastatic head and neck squamous cell carcinoma(LEAP010)

LEARN MORE

A study of MGA271 in Combination with pembrolizumab and in combination with MGA012 in Patients with Melanoma, Squamous Cell Cancer of the Head and Neck, Non-Small Cell Lung Cancer, Urothelial Cancer, and other cancers (CP-MGA271-03)

Phase I

LEARN MORE

VIEW ALL CLINICAL TRIALS

Events
News

VIEW ALL EVENTS

Jun

20

Annual Midwest Regional ASCO Review 2020

June 20, 2020 - 7:00am to 1:30pm

Learn More

VIEW ALL EVENTS

Become a NOS Member Today!

Platinum Corporate Members

Gold Corporate Members